<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Plasvacc USA</provider_name><provider_url>https://plasvacc.com/us/</provider_url><author_name>plasvacc</author_name><author_url>https://plasvacc.com/us/author/plasvacc/</author_url><title>Plasvacc Expands to UK, Acquiring Veterinary Immunogenics - Plasvacc USA</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="z2p2YXbQwX"&gt;&lt;a href="https://plasvacc.com/us/plasvacc-expands-to-uk/"&gt;Plasvacc Expands to UK, Acquiring Veterinary Immunogenics&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://plasvacc.com/us/plasvacc-expands-to-uk/embed/#?secret=z2p2YXbQwX" width="600" height="338" title="&#x201C;Plasvacc Expands to UK, Acquiring Veterinary Immunogenics&#x201D; &#x2014; Plasvacc USA" data-secret="z2p2YXbQwX" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://plasvacc.com/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://plasvacc.com/wp-content/uploads/2022/06/PV-AUS-Tamara.jpg</thumbnail_url><thumbnail_width>400</thumbnail_width><thumbnail_height>500</thumbnail_height><description>PENRITH, UNITED KINGDOM &#x2014; Plasvacc UK Ltd. is pleased to announce its entry into the United Kingdom through its acquisition of Veterinary Immunogenics Inc. Effective immediately, Plasvacc will undertake the day-to-day management of Veterinary Immunogenics under the oversight of site manager Fergus Macarthur. Incorporated in 1992, Veterinary Immunogenics has been producing and supplying hyperimmunized equine plasma products for veterinary use ... Read More</description></oembed>
